EUVIMEDEUVIMED entdecken
Crossref

Morbi-mortality of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type

Corentin Deniaud, Benoit Mesnard, Soline Bobet, Marie-Aimée Perrouin-Verbe, Julien Branchereau, Stéphane De Vergie, Jérôme Rigaud

Journal of Robotic Surgery · 2026

DOI: 10.1007/s11701-025-03059-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Robotic Surgery, 2026. Verfasst von Corentin Deniaud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital of Nantes, 1, Place Alexis- Ricordeau, Nantes Cedex 1, 44093, France. corentin.deniaud@chu-nantes.fr. Hauptthemen laut MEDLINE: Cystectomy, Robotic Surgical Procedures, Urinary Diversion, Urinary Bladder Neoplasms. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To compare early and late complications rates after robot-assisted radical cystectomy for muscle invasive bladder tumors and certain high-risk non-muscle-invasive tumors according to the type of reconstruction. We conducted a single-center retrospective study including 109 patients who underwent robot-assisted radical cystectomy between 2008 and 2022. Patients were divided into two groups based on urinary diversion: extracorporeal Bricker ileal conduit (n = 74) or orthotopic neobladder (n = 35). Complications were graded by the Clavien-Dindo classification. Multivariate analysis identified independent risk factors for morbidity and mortality. Operative time was significantly longer for neobladder reconstruction (320 vs. 291 min, p = 0.047), as was hospital stay (14 vs. 10 days, p 30 days), which affected 47.7% of patients. Operative time was an independent risk factor for major complications (OR = 1.15 per additional 15 min). Neobladder reconstruction was associated with increased early morbidity, mainly minor, without impact on late morbidity or mortality. Urinary diversion choice should be guided by patient profile and expected functional benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystectomyRobotic Surgical ProceduresUrinary DiversionUrinary Bladder NeoplasmsPostoperative ComplicationsHumansFemaleMaleRetrospective StudiesMiddle AgedAgedOperative TimeRisk FactorsLength of Stay

Stichwörter der Autor:innen

Bladder cancerMorbidity, mortality, urinary diversionRobotic-assisted radical cystectomy

Autor:innen und Institutionen

  • Department of Urology, University Hospital of Nantes, 1, Place Alexis- Ricordeau, Nantes Cedex 1, 44093, France. corentin.deniaud@chu-nantes.fr.
  • Department of Urology, University Hospital of Nantes, 1, Place Alexis- Ricordeau, Nantes Cedex 1, 44093, France.
  • Department of Clinical Database, University Hospital of Nantes, Nantes, France.

Zitieren

APA

Deniaud, C., Mesnard, B., Bobet, S., Perrouin-Verbe, M. A., Branchereau, J., De Vergie, S., & Rigaud, J. (2026). Morbi-mortality of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-025-03059-w

Vancouver

Deniaud C, Mesnard B, Bobet S, Perrouin-Verbe MA, Branchereau J, De Vergie S, et al. Morbi-mortality of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type. Journal of Robotic Surgery. 2026. doi:10.1007/s11701-025-03059-w

BibTeX
@article{Deniaud2026,
  author = {Deniaud, Corentin and Mesnard, Benoit and Bobet, Soline and Perrouin-Verbe, Marie-Aimée and Branchereau, Julien and De Vergie, Stéphane and Rigaud, Jérôme},
  title = {Morbi-mortality of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type},
  journal = {Journal of Robotic Surgery},
  year = {2026},
  doi = {10.1007/s11701-025-03059-w}
}
Kostenlos starten →